Appello Pharma completes Series A to advance treatment of Parkinson's

Guest User

by: VNC Venture Nashville Connections

Discovery shows how to treat heart attacks; drug development underway

VU319 Shows Safe Profile and Potential as M1 Allosteric Modulator for MCI